LAUSR

Indian Journal of Psychiatry Volume 59, Issue 3, July-September 2017 393 adverse drug reactions (ADRs) and alerting physicians to the plausibility and degree of such events, thereby protecting the user population from unnecessary harm.[2,3] Different classes of psychotropic medications and medications used for the treatment of substance-use disorders have different ADR profile. In addition, polypharmacy, i.e., prescribing more than one drug to the single person of the same chemical class (such as antipsychotics), can result in serious adverse reactions and exacerbate side effects and can lead to early death. PvPI encourages all types of suspected ADRs reporting whether they are known, unknown, serious, nonserious, frequent, or rare regardless of an established causal relationship between a drug and the reaction. ADRs related to the use of allopathic medicines, vaccines, traditional medicines, medical devices, contrast media, etc., can be reported to the PvPI. Regular and informed reporting practices can result in strengthened database about ADR, especially those which have late onset, or vary by genetic stock. Specific forms, endorsed by the PvPI, are available for Sir,